Conference Program Home
  My Program

All Times EDT

Abstract Details

Activity Number: 476 - Beyond Propensity Scores: Novel Techniques in Utilizing Real-World Data in Clinical Trials
Type: Topic Contributed
Date/Time: Wednesday, August 10, 2022 : 2:00 PM to 3:50 PM
Sponsor: ENAR
Abstract #322113
Title: Power Priors with Entropy Balancing Weights in Data Augmentation of Partially Controlled Randomized Trials
Author(s): Guanglei Yu and Yuanyuan Bian* and Margaret Gamalo
Companies: Eli Lilly and Company and Eli Lilly and Company and Pfizer Inc.
Keywords: Bayesian augmented control; entropy balancing; power prior; historical borrowing
Abstract:

In pediatric or orphan diseases, there are many instances where it is unfeasible to conduct randomized and controlled clinical trials due to difficulty of enrollment. One solution to reduce the sample size or expedite the trial timeline is to complement the current trial with real-world data. Several propensity score-based methods have been developed to create defined groups of patients that are controlled for confounding based on a set of measured covariates at baseline. However, balance checking on the measured covariates and tweaks to the propensity score models are usually inevitable to achieve the joint balance across all covariates. To mitigate this iterative procedure, we utilize the entropy balancing weighting technique which focuses on balancing the covariates of subjects between the experimental and control groups directly and augments the current trial with the external control data via a power prior. The operating characteristics of the proposed method are assessed via simulations, comparing with other propensity score based methods, such as covariate-balancing propensity score (CBPS) and propensity score matching (PSM) and weighting (PSW).


Authors who are presenting talks have a * after their name.

Back to the full JSM 2022 program